CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 6.12 HKD 6.43% Market Closed
Market Cap: 9B HKD

Operating Margin
CStone Pharmaceuticals

-175%
Current
-151%
Average
-3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-175%
=
Operating Profit
-354.4m
/
Revenue
202.5m

Operating Margin Across Competitors

No Stocks Found

CStone Pharmaceuticals
Glance View

Market Cap
8.4B HKD
Industry
Biotechnology

Cstone Pharmaceuticals Co. Ltd. engages in the research and development of highly complex biopharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 264 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The firm conducts its businesses mainly in domestic market.

CStone Pharmaceuticals Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-175%
=
Operating Profit
-354.4m
/
Revenue
202.5m
What is the Operating Margin of CStone Pharmaceuticals?

Based on CStone Pharmaceuticals's most recent financial statements, the company has Operating Margin of -175%.

Back to Top